During 'National Pet Cancer Awareness Month', biotech company PharmAust is calling out for dogs to help evaluate a new anti-cancer drug (MPL) shown to be safe and effective in preliminary trials. The dogs must be newly diagnosed with B-cell lymphoma and have not started any treatment.

The MPL program involves two consultations/treatments at the Animal Referral Hospital in Homebush. PharmAust will cover all compassionate use program costs, including travel expenses to and from the ARH, as well as costs for the initial conventional chemotherapy treatment upon program completion.

For more information on program entry criteria, see attached Adobe Download  or contact veterinary cancer specialist Dr Angela Frimberger on